Consolidated Statements of Income

                   
In millions, except per share data
Years ended December 31
  
08
    
07
    
06
  
Revenues
                  
Premiums
$
57,101.0
  
$
55,865.0
  
$
51,971.9
  
Administrative fees
  
3,836.6
    
3,673.6
    
3,594.8
  
Other revenue
  
641.6
    
617.0
    
613.1
  
Total operating revenue
  
61,579.2
    
60,155.6
    
56,179.8
  
Net investment income
  
851.1
    
1,001.1
    
878.7
  
Net realized (losses) gains on investments
  
(1,179.2
)
  
11.2
    
(0.3
)
Total revenues
  
61,251.1
    
61,167.9
    
57,058.2
  
Expenses
                  
Benefit expense
  
47,742.4
    
46,037.2
    
42,192.0
  
Selling, general and administrative expense
                  
Selling expense
  
1,778.4
    
1,716.8
    
1,654.5
  
General and administrative expense
  
7,242.1
    
6,984.7
    
7,163.2
  
Total selling, general and administrative expense
  
9,020.5
    
8,701.5
    
8,817.7
  
Cost of drugs
  
468.5
    
432.7
    
433.2
  
Interest expense
  
469.8
    
447.9
    
403.5
  
Amortization of other intangible assets
  
286.1
    
290.7
    
297.4
  
Impairment of intangible assets
  
141.4
    
–
    
–
  
Total expenses
  
58,128.7
    
55,910.0
    
52,143.8
  
Income before income tax expense
  
3,122.4
    
5,257.9
    
4,914.4
  
Income tax expense
  
631.7
    
1,912.5
    
1,819.5
  
Net income
$
2,490.7
  
$
3,345.4
  
$
3,094.9
  
Net income per share
                  
Basic
$
4.79
  
$
5.64
  
$
4.93
  
Diluted
$
4.76
  
$
5.56
  
$
4.82
  
The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2008 Annual Report on Form 10-K.